October 16, 2020, SAN DIEGO — WinSanTor is thrilled to announce that it was awarded a Silver designation on the Pepperdine Graziadio Business School’s third annual Most Fundable Companies® List. WinSanTor competed against over 4,500 early-stage U.S. startups spanning all 50 states, all with less than $10 million in annual revenue to be named among a list of twenty. The Most Fundable Companies initiative is designed to educate founders on the investor diligence process and recognize exceptional entrepreneurs who are solving today’s problems with inventive solutions and are also seeking investment capital to fuel their company’s growth.
WinSanTor is developing what may be the only disease-modifying treatment for peripheral neuropathy, a debilitating neurodegenerative condition that affects the lives of hundreds of millions of people.
“Since starting Company in 2011, we’ve been focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo- and HIV-induced peripheral neuropathy, and others. The Most Fundable Companies initiative provided us with a data-driven analysis that has enhanced our company strategy and has already been incorporated into our fundraising activities,” said WinSanTor. “It’s extremely validating that Pepperdine Graziadio Business School is recognizing entrepreneurs throughout the country, and providing resources to assist startups in securing private capital to accelerate meaningful innovation across industries and communities.”
The Most Fundable Companies initiative involved a multi-phase assessment that evaluated several company variables including financial projections, market opportunity, intellectual property and the strength of the management team, all of which were used to produce a fundability score. The Pepperdine Most Fundable Companies were evaluated and selected based on their readiness for private investment. Most Fundable Companies is powered by The Venture Alliance.
As a winner on the Most Fundable Companies List, WinSanTor will be profiled on Entrepreneur.com and will be featured in the December print issue of the magazine. For a complete list of the winners, visit www.pepperdine.edu/mfc-list, where you can also vote for WinSanTor as the “crowd favorite” through November 1.
Visit www.winsantor.com to learn more.
Disclaimers: The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It does not constitute investment advice, nor is it an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.
ABOUT COMPANY: WinSanTor Inc. is a San Diego-based clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo- and HIV-induced peripheral neuropathy, and others.
Contact: Stanley Kim